11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature
Sign Up to like & getrecommendations! Published in 2020 at "Endocrine"
DOI: 10.1007/s12020-020-02474-3
Abstract: Adrenal masses are commonly encountered in clinical practice, many of whom are incidental. Identifying malignancy, and excess hormone production is essential for appropriate management. Biochemical workup and imaging tests (dedicated adrenal CT and/or MRI) are… read more here.
Keywords: 11c metomidate; primary aldosteronism; adrenal masses; review ... See more keywords
Parametric mapping for 11C-metomidate PET-computed tomography imaging in the study of primary aldosteronism.
Sign Up to like & getrecommendations! Published in 2021 at "Nuclear medicine communications"
DOI: 10.1097/mnm.0000000000001477
Abstract: OBJECTIVE 11C-metomidate (11C-MTO) PET-computed tomography (CT) imaging has shown good sensitivity and specificity for the classification of bilateral or unilateral overexpression of aldosterone. This work seeks to investigate the usefulness of parametric maps via kinetic… read more here.
Keywords: metomidate pet; pet computed; pet; computed tomography ... See more keywords
Predicting Treatment Response in Primary Aldosteronism Using 11C-Metomidate Positron Emission Tomography
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Nuclear Medicine"
DOI: 10.1097/rlu.0000000000004369
Abstract: Background Appropriate treatment of primary aldosteronism (PA) depends on accurate lateralization. 11C-metomidate (MTO) is a tracer used in PET that provides functional information about the adrenal cortex. We aimed to perform MTO PET for patients… read more here.
Keywords: hsuvmax lsuvmax; 11c metomidate; primary aldosteronism; lateralization ... See more keywords